In this role, you’ll write two to three stories a day and will cover daily news on the biotech and pharma industries. You’ll coordinate closely with our US-based team and our global editors, getting ahead of the American morning to get our coverage out on time.
Stories range from a few hundred words on fast-moving news items like clinical trial results, M&A deals and CEO changes, to longer reporting-driven pieces on business and scientific developments. You’ll react to news and write a lot of copy, and we’re busy enough that there will be ample opportunities for ambitious candidates to hunt scoops and get involved in bigger projects as they learn the beat and grow as a journalist.
You’re the right candidate if you have one to two years of experience covering biotech, pharma or medical science for a trade or specialty publication. You should know what a p-value is and the difference between a biologic and a small molecule, and be ready to expand your skills as a reporter and writer with coaching and support from the team.
This role is part of a group of journalists who report to our deputy editor for newsletters.
To apply, go here.
Adam Duerson, the editor in chief of Front Office Sports, has left the sports news…
Wall Street Journal reporter Rachel Wolfe is now covering the consumer economy, looking at how people spent…
John Hayes, a stalwart of the Financial Times’ sub-editing desk, has died at the age…
Fortune is hiring a Global News Director to oversee breaking news coverage across Europe, the…
David Szymanski, a business journalist in the Tampa Bay area dating back to the 1980s,…
Charlotte Tobitt of Press Gazette interviewed Wall Street Journal editor in chief Emma Tucker on how it can…